Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Psychopharmacology is an increasingly important aspect of child and adolescent psychiatry. The evidence base for the psychopharmacological treatment of depression, anxiety, schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD) and attentiondeficit hyperactivity disorder (ADHD) is increasing. This article presents a synthesis of the information from randomised controlled trials, metaanalyses and the UK NICE guidelines as an aid to practical psychopharmacology.

Original publication

DOI

10.1192/apt.bp.114.013193

Type

Journal article

Journal

BJ Psych Advances

Publication Date

01/01/2015

Volume

21

Pages

387 - 395